Question 1

What is Regeneron Pharmaceuticals's P/S ratio?

Accepted Answer

Regeneron Pharmaceuticals (REGN) P/S ratio is 4.6× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Regeneron Pharmaceuticals?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Regeneron Pharmaceuticals specifically, the relevant sector benchmark is the current sector median of 3.5×.

Question 5

Is Regeneron Pharmaceuticals's P/S ratio high or low?

Accepted Answer

Regeneron Pharmaceuticals's P/S ratio of 4.6× is below its own 5-year average of 5.8× and above the sector median of 3.5×. That places the current reading at the 17th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Regeneron Pharmaceuticals's historical P/S ratio range?

Accepted Answer

In the available daily series, Regeneron Pharmaceuticals (REGN) P/S ratio has ranged from a low of 2.2× in 2005 to a high of 54.0× in 2002. The 5-year average is 5.8× and the 5-year median is 5.5×.

Question 7

What was Regeneron Pharmaceuticals's P/S ratio in 2025?

Accepted Answer

Regeneron Pharmaceuticals (REGN) P/S ratio at the end of 2025 was 5.5×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Regeneron Pharmaceuticals's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$79.43B	$14.34B	5.5×	+0.1×	Dec 31, 2025
2024	$76.86B	$14.20B	5.4×	-1.7×	Dec 31, 2024
2023	$93.63B	$13.12B	7.1×	+0.8×	Dec 31, 2023
2022	$77.20B	$12.17B	6.3×	+2.2×	Dec 31, 2022
2021	$67.07B	$16.07B	4.2×	-1.8×	Dec 31, 2021
2020	$50.92B	$8.50B	6.0×	-0.6×	Dec 31, 2020
2019	$42.92B	$6.56B	6.5×	+0.2×	Dec 31, 2019
2018	$42.86B	$6.71B	6.4×	-1.0×	Dec 31, 2018
2017	$43.56B	$5.87B	7.4×	-1.3×	Dec 31, 2017
2016	$42.50B	$4.86B	8.7×	-6.5×	Dec 31, 2016
2015	$62.70B	$4.10B	15.3×	-1.3×	Dec 31, 2015
2014	$46.87B	$2.82B	16.6×	-0.6×	Dec 31, 2014
2013	$36.31B	$2.10B	17.3×	+3.5×	Dec 31, 2013
2012	$18.89B	$1.38B	13.7×	+2.3×	Dec 31, 2012
2011	$5.09B	$445.82M	11.4×	+5.2×	Dec 31, 2011
2010	$2.87B	$459.07M	6.3×	+1.1×	Dec 31, 2010
2009	$1.94B	$379.27M	5.1×	-1.0×	Dec 31, 2009
2008	$1.45B	$238.46M	6.1×	-9.1×	Dec 31, 2008
2007	$1.90B	$125.02M	15.2×	-5.6×	Dec 31, 2007
2006	$1.32B	$63.45M	20.7×	+7.3×	Dec 31, 2006
2005	$891.85M	$66.19M	13.5×	+10.5×	Dec 31, 2005
2004	$511.54M	$174.02M	2.9×	-10.7×	Dec 31, 2004
2003	$809.01M	$59.33M	13.6×	-23.5×	Dec 31, 2003
2002	$816.53M	$21.99M	37.1×	-12.5×	Dec 31, 2002
2001	$1.23B	$24.75M	49.7×	—	Dec 31, 2001


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Regeneron Pharmaceuticals (REGN)

P/S Ratio daily chart for Regeneron Pharmaceuticals (REGN)

Historical P/S Ratio for Regeneron Pharmaceuticals (REGN) from 2001 to 2025

About P/S Ratio at Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals P/S Ratio by Year

Regeneron Pharmaceuticals P/S Ratio 2025: 5.5×

Regeneron Pharmaceuticals P/S Ratio 2024: 5.4×

Regeneron Pharmaceuticals P/S Ratio 2023: 7.1×

Regeneron Pharmaceuticals P/S Ratio 2022: 6.3×

Regeneron Pharmaceuticals P/S Ratio 2021: 4.2×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Regeneron Pharmaceuticals (REGN) Key Financials

P/S Ratio daily chart for Regeneron Pharmaceuticals (REGN)

Historical P/S Ratio for Regeneron Pharmaceuticals (REGN) from 2001 to 2025

About P/S Ratio at Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals P/S Ratio by Year

Regeneron Pharmaceuticals P/S Ratio 2025: 5.5×

Regeneron Pharmaceuticals P/S Ratio 2024: 5.4×

Regeneron Pharmaceuticals P/S Ratio 2023: 7.1×

Regeneron Pharmaceuticals P/S Ratio 2022: 6.3×

Regeneron Pharmaceuticals P/S Ratio 2021: 4.2×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is Regeneron Pharmaceuticals's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for Regeneron Pharmaceuticals?

+Is Regeneron Pharmaceuticals's P/S ratio high or low?

+What is Regeneron Pharmaceuticals's historical P/S ratio range?

+What was Regeneron Pharmaceuticals's P/S ratio in 2025?

+Why does Regeneron Pharmaceuticals's P/S ratio change over time?

Regeneron Pharmaceuticals (REGN) Key Financials